These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 29327910)

  • 1. Local recurrence in patients treated for rectal cancer using total mesorectal excision or transection of mesorectum.
    Vojnosanit Pregl; 2016 Oct; 73(10):927-33. PubMed ID: 29327910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial Mesorectal Excision for Rectal Adenocarcinoma: Morbidity and Oncological Outcome.
    Kanso F; Lefevre JH; Svrcek M; Chafai N; Parc Y; Tiret E
    Clin Colorectal Cancer; 2016 Mar; 15(1):82-90.e1. PubMed ID: 26372333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer of the upper rectum.
    Bondeven P
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients.
    Law WL; Chu KW
    Ann Surg; 2004 Aug; 240(2):260-8. PubMed ID: 15273550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors that influence the adequacy of total mesorectal excision for rectal cancer.
    Jeyarajah S; Sutton CD; Miller AS; Hemingway D;
    Colorectal Dis; 2007 Nov; 9(9):808-15. PubMed ID: 17441969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local excision of T1 and T2 rectal cancer: proceed with caution.
    Elmessiry MM; Van Koughnett JA; Maya A; DaSilva G; Wexner SD; Bejarano P; Berho M
    Colorectal Dis; 2014 Sep; 16(9):703-9. PubMed ID: 24787457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical treatment of adenocarcinoma of the rectum.
    Zaheer S; Pemberton JH; Farouk R; Dozois RR; Wolff BG; Ilstrup D
    Ann Surg; 1998 Jun; 227(6):800-11. PubMed ID: 9637543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total mesorectal excision for mid and low rectal cancer: Laparoscopic vs robotic surgery.
    Feroci F; Vannucchi A; Bianchi PP; Cantafio S; Garzi A; Formisano G; Scatizzi M
    World J Gastroenterol; 2016 Apr; 22(13):3602-10. PubMed ID: 27053852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
    Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y;
    Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
    Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
    J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between mesorectal grading and oncological outcome in rectal adenocarcinoma.
    Silva-Velazco J; Stocchi L; Valente MA; Church JM; Liska D; Gorgun E; Kalady MF; Kessler H; Steele SR; Delaney CP
    Colorectal Dis; 2019 Mar; 21(3):315-325. PubMed ID: 30565830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesorectal grades predict recurrences after curative resection for rectal cancer.
    Maslekar S; Sharma A; Macdonald A; Gunn J; Monson JR; Hartley JE
    Dis Colon Rectum; 2007 Feb; 50(2):168-75. PubMed ID: 17160574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Total excision of the mesorectum in cancer of the lower and middle rectum. Oncological and functional results].
    Kneist W; Heintz A; Wolf HK; Junginger T
    Chirurg; 2003 Feb; 74(2):125-31. PubMed ID: 12599030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of total mesorectal excision in middle and low rectal carcinomas.
    Tentes AA; Korakianitis OS; Veliovic D; Sgouridou E; Karagiozoglou C; Moustakas K
    J BUON; 2010; 15(1):56-60. PubMed ID: 20414928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer.
    Madbouly KM; Hussein AM; Abdelzaher E
    Am J Surg; 2014 Sep; 208(3):332-41. PubMed ID: 24581995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total mesorectal excision for rectal cancer in an unselected population: quality assessment in a low volume center.
    Ferenschild FT; Dawson I; de Wilt JH; de Graaf EJ; Groenendijk RP; Tetteroo GW
    Int J Colorectal Dis; 2009 Aug; 24(8):923-9. PubMed ID: 19488771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local recurrence after mesorectal excision for rectal cancer.
    Nesbakken A; Nygaard K; Westerheim O; Mala T; Lunde OC
    Eur J Surg Oncol; 2002 Mar; 28(2):126-34. PubMed ID: 11884047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local excision in rectal cancer patients with major or complete clinical response after neoadjuvant therapy: a case-matched study.
    Bushati M; Pucciarelli S; Gennaro N; Maretto I; Toppan P; Perin A; Urso EDL; Bagatella A; Spolverato G
    Int J Colorectal Dis; 2019 Dec; 34(12):2129-2136. PubMed ID: 31724079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suboptimal surgery and omission of neoadjuvant therapy for upper rectal cancer is associated with a high risk of local recurrence.
    Bondeven P; Laurberg S; Hagemann-Madsen RH; Ginnerup Pedersen B
    Colorectal Dis; 2015 Mar; 17(3):216-24. PubMed ID: 25510260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?
    Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J
    Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.